(Q43698610)

26 November 2017

Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans (English)

1 reference

26 November 2017

M Spitzer

1

1 reference

26 November 2017

B Franke

2

1 reference

26 November 2017

H Walter

3

1 reference

26 November 2017

J Buechler

4

1 reference

26 November 2017

A P Wunderlich

5

1 reference

26 November 2017

M Schwab

6

1 reference

26 November 2017

K A Kovar

7

1 reference

26 November 2017

L Hermle

8

1 reference

26 November 2017

G Grön

9

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

41

1 reference

26 November 2017

2

1 reference

26 November 2017

263-271

1 reference

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Vision: filling in and pop out.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

The anatomy of conscious vision: an fMRI study of visual hallucinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Memory deficits associated with recreational use of "ecstasy" (MDMA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

A modified card sorting test sensitive to frontal lobe defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

The assessment and analysis of handedness: The Edinburgh inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

The Cognitive Bias Task and lateralized frontal lobe functions in males.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Associative semantic network dysfunction in thought-disordered schizophrenic patients: direct evidence from indirect semantic priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Functional MR imaging of semantic information processing and learning-related effects using psychometrically controlled stimulation paradigms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Working memory deficits in current and previous users of MDMA ('ecstasy').

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Lateralised semantic and indirect semantic priming effects in people with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

Conjunction search revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900060-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(01)00060-0

1 reference

26 November 2017

1 reference